MaxLinear trusts plan $29.8M stock sale
MaxLinear, Inc. (symbol MXL) reports a planned sale of common stock under a Form 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MaxLinear, Inc. (symbol MXL) reports a planned sale of common stock under a Form 144. The filing lists Goldman Sachs & Co. LLC as broker and includes 351,454 shares of common stock with an associated amount of $29,789,241.04, with a proposed sale date of August 17, 2026 on NASD. The Seendripu Family Trust indicates 175,727 shares of common stock acquired as a gift on March 3, 2022. Over the past three months, the Samira Seendripu Trust #2 and the Ishan Krishna Seendripu Trust #2 each report sales of 120,000 common shares on August 14, 2026, with corresponding amounts of $10,102,332 and $10,101,180, respectively.
Key Figures
Key Terms
Form 144 regulatory
Securities To Be Sold regulatory
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does MaxLinear (MXL) disclose in this Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.